Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators..

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

2.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators..

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

3.

Influence of low back pain and prognostic value of MRI in sciatica patients in relation to back pain.

el Barzouhi A, Vleggeert-Lankamp CL, Lycklama à Nijeholt GJ, Van der Kallen BF, van den Hout WB, Koes BW, Peul WC; Leiden–The Hague Spine Intervention Prognostic Study Group..

PLoS One. 2014 Mar 17;9(3):e90800. doi: 10.1371/journal.pone.0090800. eCollection 2014.

4.

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE; VISTA-16 Investigators..

JAMA. 2014 Jan 15;311(3):252-62. doi: 10.1001/jama.2013.282836.

PMID:
24247616
5.

Back pain's association with vertebral end-plate signal changes in sciatica.

el Barzouhi A, Vleggeert-Lankamp CL, van der Kallen BF, Lycklama à Nijeholt GJ, van den Hout WB, Koes BW, Peul WC; Leiden–The Hague Spine Intervention Prognostic Study Group..

Spine J. 2014 Feb 1;14(2):225-33. doi: 10.1016/j.spinee.2013.08.058. Epub 2013 Nov 13.

PMID:
24239802
6.

Surgery versus prolonged conservative treatment for sciatica: 5-year results of a randomised controlled trial.

Lequin MB, Verbaan D, Jacobs WC, Brand R, Bouma GJ, Vandertop WP, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group.; WCP.; BWK.; RTWMT.; WBvdH.; RB..

BMJ Open. 2013 May 28;3(5). pii: e002534. doi: 10.1136/bmjopen-2012-002534.

7.

Magnetic resonance imaging in follow-up assessment of sciatica.

el Barzouhi A, Vleggeert-Lankamp CL, Lycklama à Nijeholt GJ, Van der Kallen BF, van den Hout WB, Jacobs WC, Koes BW, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group..

N Engl J Med. 2013 Mar 14;368(11):999-1007. doi: 10.1056/NEJMoa1209250.

8.

The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus.

Wikkelsø C, Hellström P, Klinge PM, Tans JT; European iNPH Multicentre Study Group..

J Neurol Neurosurg Psychiatry. 2013 May;84(5):562-8. doi: 10.1136/jnnp-2012-303314. Epub 2012 Dec 18.

PMID:
23250963
9.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators..

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

10.

A new scale for assessment of severity and outcome in iNPH.

Hellström P, Klinge P, Tans J, Wikkelsø C.

Acta Neurol Scand. 2012 Oct;126(4):229-37. doi: 10.1111/j.1600-0404.2012.01677.x. Epub 2012 May 16.

PMID:
22587624
11.

One-year outcome in the European multicentre study on iNPH.

Klinge P, Hellström P, Tans J, Wikkelsø C; European iNPH Multicentre Study Group..

Acta Neurol Scand. 2012 Sep;126(3):145-53. doi: 10.1111/j.1600-0404.2012.01676.x. Epub 2012 May 10.

PMID:
22571428
12.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators..

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

13.

The neuropsychology of iNPH: findings and evaluation of tests in the European multicentre study.

Hellström P, Klinge P, Tans J, Wikkelsø C.

Clin Neurol Neurosurg. 2012 Feb;114(2):130-4. doi: 10.1016/j.clineuro.2011.09.014. Epub 2011 Oct 22.

PMID:
22023722
14.

Interobserver agreement on MRI evaluation of patients with cervical radiculopathy.

Kuijper B, Beelen A, van der Kallen BF, Nollet F, Lycklama A Nijeholt GJ, de Visser M, Tans JT.

Clin Radiol. 2011 Jan;66(1):25-9. doi: 10.1016/j.crad.2010.07.010.

PMID:
21147295
15.

Root compression on MRI compared with clinical findings in patients with recent onset cervical radiculopathy.

Kuijper B, Tans JT, van der Kallen BF, Nollet F, Lycklama A Nijeholt GJ, de Visser M.

J Neurol Neurosurg Psychiatry. 2011 May;82(5):561-3. doi: 10.1136/jnnp.2010.217182. Epub 2010 Nov 3.

PMID:
21047885
16.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators..

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
17.

Cervical collar or physiotherapy versus wait and see policy for recent onset cervical radiculopathy: randomised trial.

Kuijper B, Tans JT, Beelen A, Nollet F, de Visser M.

BMJ. 2009 Oct 7;339:b3883. doi: 10.1136/bmj.b3883.

18.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators..

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

19.

Effect of dronedarone on cardiovascular events in atrial fibrillation.

Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ; ATHENA Investigators..

N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778. Erratum in: N Engl J Med. 2009 Jun 4;360(23):2487. N Engl J Med. 2011 Apr 14;364(15):1481.

20.

Degenerative cervical radiculopathy: diagnosis and conservative treatment. A review.

Kuijper B, Tans JT, Schimsheimer RJ, van der Kallen BF, Beelen A, Nollet F, de Visser M.

Eur J Neurol. 2009 Jan;16(1):15-20. doi: 10.1111/j.1468-1331.2008.02365.x. Review.

PMID:
19087147

Supplemental Content

Loading ...
Support Center